Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Oxidative Stress And Mitochondrial DNA Damage In Heart Failure.

H. Tsutsui, S. Kinugawa, S. Matsushima
Published 2008 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Recent experimental and clinical studies have suggested that oxidative stress is enhanced in heart failure. The production of oxygen radicals is increased in the failing heart while antioxidant enzyme activities are preserved. Mitochondrial electron transport is an enzymatic source of oxygen radical generation and also a target against oxidant-induced damage in the failing myocardium. Chronic increases in oxygen radical production in the mitochondria can lead to a catastrophic cycle of mitochondrial DNA (mtDNA) damage, as well as functional decline, further oxygen radical generation, and cellular injury. Reactive oxygen species induce myocyte hypertrophy, apoptosis, and interstitial fibrosis by activating matrix metalloproteinases. These cellular events play an important role in the development and progression of maladaptive cardiac remodeling and failure. Therefore, oxidative stress and mtDNA damage are good therapeutic targets. Overexpression of peroxiredoxin-3 (Prx-3), mitochondrial antioxidant, or mitochondrial transcription factor A (TFAM) could ameliorate the decline in mtDNA copy number in failing hearts. Consistent with alterations in mtDNA, the decrease in oxidative capacities is also prevented. Therefore, the activation of Prx-3 or TFAM expression could ameliorate the pathophysiological processes seen in myocardial failure. Inhibition of oxidative stress and mtDNA damage could be novel and potentially effective treatment strategies for heart failure.
This paper references
Hydroxyl radical generation during mitochondrial electron transfer and the formation of 8-hydroxydesoxyguanosine in mitochondrial DNA.
C. Giulivi (1995)
Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres.
J. Lin (2002)
Increased superoxide in heart failure: a biochemical baroreflex gone awry.
T. Muenzel (1999)
Mitochondrial DNA maintenance in vertebrates.
G. Shadel (1997)
Greater susceptibility of failing cardiac myocytes to oxygen free radical-mediated injury.
H. Tsutsui (2001)
Biogenesis of mitochondria.
G. Attardi (1988)
Mitochondrial oxidative stress in heart failure: "oxygen wastage" revisited.
D. Sawyer (2000)
Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats.
M. Hill (1996)
Buthionine sulfoximine reduces the protective capacity of myocytes to withstand peroxide-derived free radical attack.
C. T. Lê (1993)
Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro.
D. Siwik (1999)
Enhanced Generation of Reactive Oxygen Species in the Limb Skeletal Muscles From a Murine Infarct Model of Heart Failure
HiroyukiTsutsui (2001)
Oxygen-derived free radicals in postischemic tissue injury.
J. McCord (1985)
Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease.
M. Corral-Debrinski (1992)
Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function.
F. Spinale (1998)
Energy metabolism in heart failure
R. Ventura-Clapier (2004)
Overexpression of Mitochondrial Peroxiredoxin-3 Prevents Left Ventricular Remodeling and Failure After Myocardial Infarction in Mice
ShoujiMatsushima (2006)
Virtual imaging for teaching cardiac embryology.
J. Schleich (2001)
Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction.
S. Hayashidani (2003)
Time-Dependent and Tissue-Specific Accumulation of mtDNA and Respiratory Chain Defects in Chronic Doxorubicin Cardiomyopathy
D. Lebrecht (2003)
Mitochondrial diseases in man and mouse.
D. Wallace (1999)
Human mitochondrial DNA is packaged with TFAM.
Tanfis Istiaq Alam (2003)
Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.
S. Rajagopalan (1996)
Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1
Z. Wu (1999)
Nuclear receptor signaling and cardiac energetics.
J. Huss (2004)
Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects.
R. Anan (1995)
Mitochondrial dysfunction in Parkinson's disease.
J. T. Greenamyre (1999)
Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy.
E. Arbustini (1998)
Regulation of mitochondrial D‐loops by transcription factor A and single‐stranded DNA‐binding protein
C. Takamatsu (2002)
Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium.
T. Ide (2000)
Mitochondrial Electron Transport Complex I Is a Potential Source of Oxygen Free Radicals in the Failing Myocardium
TomomiIde (1999)
Premature ageing in mice expressing defective mitochondrial DNA polymerase
A. Trifunović (2004)
Overexpression of glutathione peroxidase attenuates myocardial remodeling and preserves diastolic function in diabetic heart.
S. Matsushima (2006)
Limited Exercise Capacity in Heterozygous Manganese Superoxide Dismutase Gene–Knockout Mice: Roles of Superoxide Anion and Nitric Oxide
S. Kinugawa (2005)
Cardiac-Specific Induction of the Transcriptional Coactivator Peroxisome Proliferator-Activated Receptor &ggr; Coactivator-1&agr; Promotes Mitochondrial Biogenesis and Reversible Cardiomyopathy in a Developmental Stage-Dependent Manner
Laurie K. Russell (2004)
Replication and transcription of vertebrate mitochondrial DNA.
D. Clayton (1991)
Elevated levels of 8-iso-prostaglandin F2alpha in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure.
Z. Mallat (1998)
Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice.
L. Rohde (1999)
Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles
A. Garnier (2003)
Frontotemporal dementia: Neuropil spheroids and presynaptic terminal degeneration
L. Zhou (1998)
Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells.
S. Ballinger (2000)
Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure.
M. Sullivan (1990)
Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice
塩見 哲也 (2005)
Mitochondrial transcription factor A is necessary for mtDNA maintance and embryogenesis in mice
N. Larsson (1998)
Reduced activity of mtTFA decreases the transcription in mitochondria isolated from diabetic rat heart.
A. Kanazawa (2002)
Reduction and Restoration of Mitochondrial DNA Content After Focal Cerebral Ischemia/Reperfusion
H. Chen (2001)
Treatment With Dimethylthiourea Prevents Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction in Mice: Role of Oxidative Stress
S. Kinugawa (2000)
The epidemiology of heart failure: the Framingham Study.
K. Ho (1993)
Matrix Metalloproteinase Inhibition After Myocardial Infarction: A New Approach to Prevent Heart Failure?
E. Creemers (2001)
Nuclear activators and coactivators in mammalian mitochondrial biogenesis.
R. Scarpulla (2002)
Canaries in the coal mine: mitochondrial DNA and vascular injury from reactive oxygen species.
R. Williams (2000)
Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production.
J. Bauersachs (1999)
Mitochondrial gene expression in mammalian striated muscle. Evidence that variation in gene dosage is the major regulatory event.
R. Williams (1986)
Dilated cardiomyopathy and atrioventricular conduction blocks induced by heart-specific inactivation of mitochondrial DNA gene expression
J. Wang (1999)
Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction
井手 友美 (2001)
Mitochondrial transcription factor A regulates mtDNA copy number in mammals.
Mats I Ekstrand (2004)
Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor
F. Naya (2002)
The relationship between somatic mtDNA rearrangements, human heart disease and aging.
O. Kajander (2002)
Oxidative stress is related to exercise intolerance in patients with heart failure.
Y. Nishiyama (1998)
Overexpression of Mitochondrial Transcription Factor A Ameliorates Mitochondrial Deficiencies and Cardiac Failure After Myocardial Infarction
MasakiIkeuchi (2005)
Regulation of mitochondrial transcription by mitochondrial transcription factor A
Julio Montoya (2004)
Exercise intolerance in heart failure. Importance of skeletal muscle.
J. Wilson (1995)
Oxygen free radicals and congestive heart failure.
J. Belch (1991)
Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction.
M. Hill (1997)
Relationship between the critical level of oxidative stresses and the glutathione peroxidase activity.
O. Toussaint (1993)
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
J. Lin (2002)

This paper is referenced by
Cardioprotective effects of luteolin during ischemia-reperfusion injury in rats.
Pei-Hu Liao (2011)
Wnt5a is elevated in heart failure and affects cardiac fibroblast function
Aurelija Abraityte (2017)
Cardioprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on Doxorubicin-induced cardiomyopathy in mice.
Hiroyoshi Mori (2010)
in a rat pneumonia-related sepsis model suppresses inflammation and improves cardiac function Specific inhibition of mitochondrial oxidative stress
Steven E. Wolf (2012)
Factors regulating the change of vascular smooth muscle cells in cardiovascular diseases: A mini review
Hao-cheng Li (2019)
Angiotensin II-induced mitochondrial reactive oxygen species and peroxiredoxin-3 expression in cardiac fibroblasts
P. Lijnen (2012)
The influence of proteasome inhibitor on the expression of cardiomyocytes damage markers after incubation with doxorubicin
Sylwia Tereszkiewicz (2014)
Rescue of Heart Failure by Mitochondrial Recovery
J. Marquez (2016)
Spontaneous development of left ventricular hypertrophy and diastolic dysfunction in mice lacking all nitric oxide synthases.
K. Shibata (2010)
Effect of temperature and salinity on mtDNA copy number of the ridgetail white prawn, Palaemon carinicauda Holthuis, 1950 (Decapoda, Palaemonidae)
Z. Li (2018)
Sepsis-induced Cardiac Mitochondrial Damage and Potential Therapeutic Interventions in the Elderly.
Q. Zang (2014)
The role of control region mitochondrial DNA mutations in cardiovascular disease: stroke and myocardial infarction
M. Umbria (2020)
Capsaicin Alleviates the Deteriorative Mitochondrial Function by Upregulating 14-3-3η in Anoxic or Anoxic/Reoxygenated Cardiomyocytes
Y. Qiao (2020)
Pharmacologic Strategies to Target Oxidative Stress in Heart Failure
Z. Ahmed (2012)
Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone
R. Damiani (2016)
Testosterone Deficiency Caused by Castration Modulates Mitochondrial Biogenesis Through the AR/PGC1α/TFAM Pathway
C. Liu (2019)
PEDF improves cardiac function in rats subjected to myocardial ischemia/reperfusion injury by inhibiting ROS generation via PEDF-R
Q. Zhao (2018)
Acetylcholine Attenuates Hypoxia/ Reoxygenation-Induced Mitochondrial and Cytosolic ROS Formation in H9c2 Cells via M2 Acetylcholine Receptor
Yi Miao (2013)
Featured Article: Accelerated decline of physical strength in peroxiredoxin-3 knockout mice
Yonggang Zhang (2016)
PKCα replaces AMPK to regulate mitophagy: Another PEDF role on ischaemic cardioprotection
Haoran Miao (2018)
Heart Failure Phenotypes Induced by Knockdown of DAPIT in Zebrafish: A New Insight into Mechanism of Dilated Cardiomyopathy
Y. Nagata (2017)
Mitochondrial ROS Induces Cardiac Inflammation via a Pathway through mtDNA Damage in a Pneumonia-Related Sepsis Model
X. Yao (2015)
Cardiovascular Disease, Mitochondria, and Traditional Chinese Medicine
J. Wang (2015)
Indicators of oxidative stress and plasma antioxidative enzyme activity in patients with different stages of heart failure
Slavica Radovanović (2011)
Mitochondrial dysfunction and its impact on diabetic heart.
S. Verma (2017)
Therapeutic Strategies for Mitochondrial Dysfunction and Oxidative Stress in Age-Related Metabolic Disorders.
J. S. Bhatti (2017)
Sepsis-Induced Cardiac Mitochondrial Dysfunction Involves Altered Mitochondrial-Localization of Tyrosine Kinase Src and Tyrosine Phosphatase SHP2
Q. Zang (2012)
The Mitochondrial T16189C Polymorphism Is Associated with Coronary Artery Disease in Middle European Populations
E. Mueller (2011)
A cross-sectional sero-survey of some infectious diseases of working equids in Central Ethiopia
M. Getachew (2014)
Effects of atorvastatin on the hypertension-induced oxidative stress in the rat brain.
M. Mohammadi (2013)
Die Bedeutung der Tissue Factor - abhängigen Signaltransduktion für die zelluläre Funktion der Kardiomyozyten
U. Boltzen (2010)
N-Acetylcysteine Ameliorates Experimental Autoimmune Myocarditis in Rats via Nitric Oxide
K. Shimada (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar